Notification of limitations on publishing review articles and articles using the molecular docking method
Dear prospective authors from the Borneo Journal of Pharmacy,
Due to the large number of submissions we receive, while our review and editing capacity is limited (only publishing 40 articles a year), we are forced to implement several policies regarding the restrictions on the types of articles that can be processed in the Borneo Journal of Pharmacy. These restrictions apply to:
1. Review Articles
We currently process many review articles, both narrative and systematic reviews (nearly 30% of the number of manuscripts processed). We apply a limit on the number of review articles in each issue of no more than 30% to accommodate original research articles, so we must limit the number of review articles that we can process. This limitation does not apply to manuscripts sent based on invitations to potential authors.
2. Articles with Molecular Docking Method
Currently, the Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya publishes a journal that explicitly publishes various articles using the molecular docking method as the primary method: Journal of Molecular Docking (http://journal.umpalangkaraya.ac.id/index.php/jmd). Considering the high traffic of articles in the Borneo Journal of Pharmacy, including those that publish articles on molecular docking, we are temporarily not accepting articles of this type. We will advise authors to move their submissions to the Journal of Molecular Docking. This limitation does not apply to manuscripts that use molecular docking as a complementary method and not the primary analysis method.
The restrictions on these two types of manuscripts will be in place for 2022 and re-evaluated at the end of 2022. Once again, we thank all authors and prospective authors from the Borneo Journal of Pharmacy.
Borneo Journal of Pharmacy